196 related articles for article (PubMed ID: 33241878)
21. Synthesis and antitumor activity of novel substituted uracil-1'(N)-acetic acid ester derivatives of 20(S)-camptothecins.
Li DZ; Zhang QZ; Wang CY; Zhang YL; Li XY; Huang JT; Liu HY; Fu ZD; Song HX; Lin JP; Ji TF; Pan XD
Eur J Med Chem; 2017 Jan; 125():1235-1246. PubMed ID: 27871039
[TBL] [Abstract][Full Text] [Related]
22. Design, synthesis and biological evaluation of lapachol derivatives possessing indole scaffolds as topoisomerase I inhibitors.
Zhang C; Qu Y; Niu B
Bioorg Med Chem; 2016 Nov; 24(22):5781-5786. PubMed ID: 27667553
[TBL] [Abstract][Full Text] [Related]
23. Synthesis and biological evaluation of 1,5-naphthyridines as topoisomerase I inhibitors. A new family of antiproliferative agents.
Alonso C; Fuertes M; González M; Rodríguez-Gascón A; Rubiales G; Palacios F
Curr Top Med Chem; 2014; 14(23):2722-8. PubMed ID: 25515747
[TBL] [Abstract][Full Text] [Related]
24. Synthesis and biological evaluations of novel indenoisoquinolines as topoisomerase I inhibitors.
Zhang X; Wang R; Zhao L; Lu N; Wang J; You Q; Li Z; Guo Q
Bioorg Med Chem Lett; 2012 Jan; 22(2):1276-81. PubMed ID: 22079759
[TBL] [Abstract][Full Text] [Related]
25. Molecular Design, Synthesis and Docking Study of Alkyl and Benzyl Derivatives of Robustic Acid as Topoisomerase I Inhibitors.
Chen R; Huang J; Jaiswal Y; Wei J; Huo L; Xia X; Zhong J; Williams L; Huang M; Liang Y
Chem Biodivers; 2020 Mar; 17(3):e1900556. PubMed ID: 31943759
[TBL] [Abstract][Full Text] [Related]
26. Synthesis and preliminary bioevaluation of novel E-ring modified acetal analog of camptothecin as cytotoxic agents.
Zhu L; Zhuang C; Lei N; Guo Z; Sheng C; Dong G; Wang S; Zhang Y; Yao J; Miao Z; Zhang W
Eur J Med Chem; 2012 Oct; 56():1-9. PubMed ID: 23084702
[TBL] [Abstract][Full Text] [Related]
27. Design, synthesis, and docking study of new quinoline derivatives as antitumor agents.
Nasr EE; Mostafa AS; El-Sayed MAA; Massoud MAM
Arch Pharm (Weinheim); 2019 Jul; 352(7):e1800355. PubMed ID: 31081954
[TBL] [Abstract][Full Text] [Related]
28. A new strategy to improve the metabolic stability of lactone: discovery of (20S,21S)-21-fluorocamptothecins as novel, hydrolytically stable topoisomerase I inhibitors.
Miao Z; Zhu L; Dong G; Zhuang C; Wu Y; Wang S; Guo Z; Liu Y; Wu S; Zhu S; Fang K; Yao J; Li J; Sheng C; Zhang W
J Med Chem; 2013 Oct; 56(20):7902-10. PubMed ID: 24069881
[TBL] [Abstract][Full Text] [Related]
29. Cytotoxicity and topo I targeting activity of substituted 10--nitrogenous heterocyclic aromatic group derivatives of SN-38.
Li QY; Deng XQ; Zu YG; Lv H; Su L; Yao L; Zhang Y; Li L
Eur J Med Chem; 2010 Jul; 45(7):3200-6. PubMed ID: 20392545
[TBL] [Abstract][Full Text] [Related]
30. Design, synthesis and evaluation of novel sophoridinic imine derivatives containing conjugated planar structure as potent anticancer agents.
Xu Y; Jing D; Chen R; Rashid HU; Jiang J; Liu X; Wang L; Xie P
Bioorg Med Chem; 2018 Aug; 26(14):4136-4144. PubMed ID: 30007563
[TBL] [Abstract][Full Text] [Related]
31. Pyridazino[1,6-b]quinazolinones as new anticancer scaffold: Synthesis, DNA intercalation, topoisomerase I inhibition and antitumor evaluation in vitro and in vivo.
Huang WY; Zhang XR; Lyu L; Wang SQ; Zhang XT
Bioorg Chem; 2020 Jun; 99():103814. PubMed ID: 32278208
[TBL] [Abstract][Full Text] [Related]
32. Synthesis and antitumor activity evaluation of a novel series of camptothecin analogs.
Lv J; Guo N; Wen SP; Teng YO; Ma MX; Yu P
J Asian Nat Prod Res; 2013; 15(8):867-74. PubMed ID: 23796391
[TBL] [Abstract][Full Text] [Related]
33. Synthesis, anticancer evaluation and molecular docking studies of new benzimidazole- 1,3,4-oxadiazole derivatives as human topoisomerase types I poison.
Acar Çevik U; Sağlık BN; Osmaniye D; Levent S; Kaya Çavuşoğlu B; Karaduman AB; Atlıd Ö; Atlı Eklioğlu Ö; Kaplancıklı ZA
J Enzyme Inhib Med Chem; 2020 Dec; 35(1):1657-1673. PubMed ID: 32811204
[TBL] [Abstract][Full Text] [Related]
34. Evolution in medicinal chemistry of E-ring-modified Camptothecin analogs as anticancer agents.
Huang Q; Wang L; Lu W
Eur J Med Chem; 2013 May; 63():746-57. PubMed ID: 23578545
[TBL] [Abstract][Full Text] [Related]
35. Design, synthesis, cytotoxic activity and molecular docking studies of new 20(S)-sulfonylamidine camptothecin derivatives.
Song ZL; Wang MJ; Li L; Wu D; Wang YH; Yan LT; Morris-Natschke SL; Liu YQ; Zhao YL; Wang CY; Liu H; Goto M; Liu H; Zhu GX; Lee KH
Eur J Med Chem; 2016 Jun; 115():109-20. PubMed ID: 26994847
[TBL] [Abstract][Full Text] [Related]
36. Design, synthesis and biological evaluation of 3-substituted indenoisoquinoline derivatives as topoisomerase I inhibitors.
Zhao Q; Xu X; Xie Z; Liu X; You Q; Guo Q; Zhong Y; Li Z
Bioorg Med Chem Lett; 2016 Feb; 26(3):1068-1072. PubMed ID: 26725027
[TBL] [Abstract][Full Text] [Related]
37. Molecular modelling design, synthesis and cytotoxic evaluation of certain substituted 2-(3,4,5-triacetoxybenzoylamino)benzo[d]thiazole and 2-(galloylamino)benzo[d]thiazole derivatives having potential topoisomerase-I inhibitory activity.
Ismail MA; Tratrat C; Haroun MG
J Enzyme Inhib Med Chem; 2013 Dec; 28(6):1331-45. PubMed ID: 22957723
[TBL] [Abstract][Full Text] [Related]
38. Synthesis and evaluation of novel ellipticines as potential anti-cancer agents.
Deane FM; O'Sullivan EC; Maguire AR; Gilbert J; Sakoff JA; McCluskey A; McCarthy FO
Org Biomol Chem; 2013 Feb; 11(8):1334-44. PubMed ID: 23314103
[TBL] [Abstract][Full Text] [Related]
39. Synthesis and evaluation of 9-benzylideneamino derivatives of homocamptothecin as potent inhibitors of DNA topoisomerase I.
Guo W; Miao Z; Sheng C; Yao J; Feng H; Zhang W; Zhu L; Liu W; Cheng P; Zhang J; Che X; Wang W; Luo C; Xu Y
Eur J Med Chem; 2010 Jun; 45(6):2223-8. PubMed ID: 20202723
[TBL] [Abstract][Full Text] [Related]
40. Novel Hybrid Molecules on the Basis of Steroids and (5Z,9Z)-Tetradeca-5,9-dienoic Acid: Synthesis, Anti-Cancer Studies and Human Topoisomerase I Inhibitory Activity.
D'yakonov VA; Dzhemileva LU; Tuktarova RA; Ishmukhametova SR; Yunusbaeva MM; Ramazanova IR; Dzhemilev UM
Anticancer Agents Med Chem; 2017; 17(8):1126-1135. PubMed ID: 27928953
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]